Intelligent Bio Solutions Inc.
INBS
$1.29
-$0.01-0.77%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -10.70M | -10.42M | -10.16M | -10.03M | -13.40M |
| Total Depreciation and Amortization | 1.23M | 1.21M | 1.21M | 1.10M | 1.17M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 386.60K | 147.40K | 74.00K | -143.90K | 3.46M |
| Change in Net Operating Assets | -1.02M | -1.59M | -701.90K | 1.87M | 1.49M |
| Cash from Operations | -10.10M | -10.65M | -9.57M | -7.21M | -7.28M |
| Capital Expenditure | -173.60K | -221.40K | -221.40K | -54.10K | -57.40K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -181.80K | -7.30K |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -173.60K | -221.40K | -221.40K | -235.90K | -64.70K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | 100.30K | 34.80K |
| Issuance of Common Stock | 13.91M | 14.60M | 14.56M | 14.56M | 3.90M |
| Repurchase of Common Stock | -- | -- | -- | 0.00 | 0.00 |
| Issuance of Preferred Stock | -- | 3.04M | 3.04M | 3.04M | 3.04M |
| Repurchase of Preferred Stock | -3.04M | -3.04M | -3.04M | -3.04M | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 571.80K | 0.00 | 0.00 | -54.20K | -1.42M |
| Cash from Financing | 11.45M | 14.60M | 14.56M | 14.60M | 5.55M |
| Foreign Exchange rate Adjustments | -49.10K | 68.50K | -600.00 | -36.50K | 5.90K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 1.12M | 3.80M | 4.77M | 7.12M | -1.79M |